Ho–Kaufman–Mcalister syndrome

From WikiMD's WELLNESSPEDIA


Ho–Kaufman–Mcalister syndrome
Synonyms Blepharo-naso-facial syndrome
Pronounce N/A
Specialty N/A
Symptoms Blepharophimosis, ptosis, epicanthus inversus, telecanthus, nasal abnormalities, facial dysmorphism
Complications N/A
Onset Congenital
Duration Lifelong
Types N/A
Causes Genetic mutation
Risks Family history
Diagnosis Clinical diagnosis, genetic testing
Differential diagnosis Blepharophimosis syndrome, Kabuki syndrome, Noonan syndrome
Prevention N/A
Treatment Surgical correction of eyelid and nasal deformities
Medication N/A
Prognosis Generally good with treatment
Frequency Rare
Deaths Not typically life-threatening


Ho–Kaufman–Mcalister syndrome is a rare genetic disorder characterized by intellectual disability, microcephaly, short stature, and distinctive facial features. The syndrome was first described by Ho, Kaufman, and Mcalister in 1987.

Symptoms and Signs[edit]

The most common symptoms of Ho–Kaufman–Mcalister syndrome include:

Other symptoms may include hypotonia (low muscle tone), seizures, and developmental delay.

Causes[edit]

Ho–Kaufman–Mcalister syndrome is a genetic disorder. It is thought to be caused by mutations in a gene, but the specific gene has not yet been identified.

Diagnosis[edit]

The diagnosis of Ho–Kaufman–Mcalister syndrome is based on the presence of characteristic clinical features. Genetic testing may be used to confirm the diagnosis.

Treatment[edit]

There is no cure for Ho–Kaufman–Mcalister syndrome. Treatment is supportive and based on the symptoms present in each individual. This may include physical therapy for hypotonia, special education for intellectual disability, and medication for seizures.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.